Clínica Ricardo Palma has sold a 50% stake to Quirónsalud
The shareholders of Administradora Clínica Ricardo Palma S.A. (Clínica Ricardo Palma) have sold 50% of their shares to Quirónsalud for an undisclosed consideration.
Clínica Ricardo Palma is a leading private clinic dedicated to providing health services in Peru.
Quirónsalud is the largest hospital operator in Spain with more than US$2 billion in revenues, 84 care centers (43 hospitals, 35 medical centers and 6 care homes), over 6,700 beds and 26,000 professionals. Quirónsalud offers patients comprehensive health care that encompasses all medical specialties.
Oaklins' team in Peru advised the seller in this transaction. After the acquisition of 50% of Clinica Ricardo Palma, Quirónsalud becomes a strategic partner.
Talk to the deal team
Related deals
Bayer AG has entered into a takeover agreement with Cara Care
Bayer AG, renowned for its advancements in healthcare and life sciences, has finalized the acquisition of Cara Care (HiDoc Technologies GmbH), which entered debtor-in-possession proceedings in October 2024. Cara Care, an innovative digital health platform and official DiGA, aligns perfectly with Bayer’s strategic focus on digital health and the expansion of its innovative solutions portfolio. The transaction is expected to close in Spring 2025.
Learn moreMark Climate Technology has acquired Heber GmbH
Heber GmbH has been acquired by Mark Climate Technology, a specialist in climate control systems and a portfolio company of Bolster Investment Partners. This partnership strengthens the positions of both companies in the global market for innovative and sustainable climate solutions, as well as creating unique synergies. Mark Climate's expertise in standardized, scalable solutions is enhanced by Heber's emphasis on customer-specific customization.
Learn moreGrupo Veta 2017 S.L. has been acquired by MSA Mizar
The Franco-Belgian fund Kartesia has sold Grupo Veta 2017 S.L. to the Italian group MSA Mizar. Kartesia, the main shareholder of Veta+ together with its founding partner, has sold 100% of the capital. For MSA Mizar, this transaction represents the consolidation of its presence in Spain, the entry into the multi-risk claims management market and the opportunity to apply Veta+’s expertise to other European markets.
Learn more